Share Name Share Symbol Market Type Share ISIN Share Description
Direct Line Insurance Group Plc LSE:DLG London Ordinary Share GB00BY9D0Y18 ORD 10 10/11P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 294.00 1,634 01:00:00
Bid Price Offer Price High Price Low Price Open Price
293.40 293.70
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Nonlife Insurance 3,214.80 451.40 25.80 11.4 3,948
Last Trade Time Trade Type Trade Size Trade Price Currency
06:45:06 O 817 294.0818 GBX

Direct Line Insurance (DLG) Latest News (1)

More Direct Line Insurance News
Direct Line Insurance Investors    Direct Line Insurance Takeover Rumours

Direct Line Insurance (DLG) Discussions and Chat

Direct Line Insurance Forums and Chat

Date Time Title Posts
21/9/202110:24Direct Line......1,706
05/12/201907:14Ideas Anyone?1
01/8/201801:53Direct Line (DLG) One to Watch on Wednesday -
09/11/201612:51*** Direct Line ***218
04/9/201408:56Why to BUY and HOLD Direct Line (DLG)-

Add a New Thread

Direct Line Insurance (DLG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-09-21 15:26:51293.60186546.10AT
2021-09-21 15:26:51293.605251,541.40AT
2021-09-21 15:26:42293.601,1843,476.22O
View all Direct Line Insurance trades in real-time

Direct Line Insurance (DLG) Top Chat Posts

Direct Line Insurance Daily Update: Direct Line Insurance Group Plc is listed in the Nonlife Insurance sector of the London Stock Exchange with ticker DLG. The last closing price for Direct Line Insurance was 294p.
Direct Line Insurance Group Plc has a 4 week average price of 289.80p and a 12 week average price of 279.80p.
The 1 year high share price is 342.10p while the 1 year low share price is currently 259.60p.
There are currently 1,342,699,566 shares in issue and the average daily traded volume is 5,887,117 shares. The market capitalisation of Direct Line Insurance Group Plc is £3,947,536,724.04.
fenners66: More waste of money share buybacks being announced here today and say at BP. BP CEO suggests they can buyback 5% of their shares annually and raise the dividend by 4% ! That is not even by the % they gain from no longer having the 5% issued. To describe buybacks as a "return to shareholders" is utter BS. Its creating a market for institutions to play their buying and selling games with, when the buybacks stop the music stops and the share price drops. Thanks for holding the shares today, here's a buyback now F-off. Rewarding shareholders , is giving them a dividend to remain shareholders.
griffmeister: Porsche, unless I'm wrong DLG are in the 250, which is at an all time...so there is clearly growth available in the UK. I can't understand your constant pessimism and on going Brit bashing. Honestly, if it's that bad in the UK then just leave. I do, however, totally agree with your DLG comments. The highs aren't as high as they used to be and the lows keep on getting lower. I will be off loading my shares before ex div date with a view to buying back in when/if the share price drops.
wba1: wolansm; my view is based on 40 years in insurance rather than market theory. The problem with DLG is that it will be more affected by price walking rules than any other UK insurer. They will need to find new ways to attract new business when the new rules kick in as they cannot loss lead. This means that a shrinking retail book in the run up to the rules is a real problem as restarting growth in their core retail book will be very difficult. The underlying question is whether they should be willing to take short term lower margins to maintain or grow the book into those rules, and then manage the book for retention more than new business. Not an easy question. And what growth they have reported throws up too many questions. If they see Darwin as a driver of profitable growth they are in for an awful shock. If you said these issues affect all insurers you would be right, but the difference is the degree of reliance of DLG on affected UK retail business. Others like Allianz, Aviva, Zurich etc have only a small part of their books in that area. But I do not see DLG as a significant downside risk as, if they do not make progress they will be taken out. The current market cap would make them an easy snack for the big players.
wba1: I share the view that the statement offers no basis for an investment (as opposed to trading the shares) unless you see it as bringing them more into play for predators. This is not to suggest they are doing badly, just that it offers no catalyst for a rerating. There are some small questions underlying the statement which would need more detail to understand properly; * The growth in Darwin. Obviously to be expected as a new development, but it is in the intermediated sector (read aggregators) where margins are wafer thin if they exist at all. * The growth in NIG/commercial. Whilst DLG are leaders in retail, they are not even significant players in commercial business (which is led by the likes of Allianz and Aviva). Are they driving the growth in sectors they understand or widening the underwriting envelope into new areas with the associated risk? * The drop in core direct retail business. In the circumstances this would not bother me except for the coming impact of price walking rules. DLG rely on loss leader prices to get new business followed by customer inertia to maintain high retention. Obviously it will have advantage to maximise the customer base when the new rules start (as getting new business will be more challenging). But the book size is going in the opposite direction. This still looks like an income and trading share only to me.
rogerramjett: I would suggest DLG have given the buy back to a firm which sets an algorithm to drive the share price down whilst they accumulate shares at the lowest possible average. Now paying greater than 7.5% dividend and approaching oversold. Will be adding today/tomorrow also.
wba1: Rogerrail; there are many more diversified insurance shares than DLG (in both UK and US), with only the likes of Admiral and Sabre with similar retail focus. But they both have different business models (Sabre is not exposed to price walking action and is a niche player and Admiral is more akin to a hybrid insurer/broker model with the Munich Re arrangement). Nothing wrong with being focused and DLG is not overvalued, but I really do not like the possible implications of price walk (or dual pricing as I always called it) action on a company whose business is almost all exposed to it. Obviously Aviva is as well (but it is a small part of their business and the overall business is much lower rated even after its recovery, and L&G is just a completely different beast. I just see DLG as a rocker play (trading between the limits) - unless it becomes a target. But only my view.
wba1: There are 2 reasons to hold rather than trade DLG. Either to tuck away for income (a decent divi is very safe going forward, even if core performance declines, due to the large surplus claims reserves they have tucked away for future release) or in the expectation of possible takeover. Putting these to one side there are better long term plays as DLG is a very focused UK retail insurance play in a sector under regulatory attack. I prefer to trade this share but can understand those who hold it - both approaches should deliver a return. I would just caution that DLG is not an exemplar in the insurance business (too focused, regulatory pressure, pricing tech easy to replicate except dataset). But the wider insurance sector remains significantly undervalued and DLG may ride up with it.
wba1: Porsche1945; I don't disagree with your sentiment but my comment about possible acquisition was (1) entirely speculative with no specific knowledge and (2) driven by the wider behaviour of the large players globally. Allianz, Generali, Zurich, Chubb are all currently active in major takeovers and there has also been PE activity. This is more than I have seen for many years. DLG is not my favourite insurer, but it does have a strong brand and a core expertise which could be used more widely by a global insurer with limited direct skills (for which read all of the previously named). Add in that the price would not be excessive and that, say, £6 billion is no issue for those named or PE, and the possibility (no more than that) of DLG coming into play exists. Of course, if the potential bidders get tied up with other big takeovers (such as the current Hartford auction) they may not want to look elsewhere. I tend to be less concerned about the likes of Lemonade. I wrote a big retail p&c book in the UK and worked with the US subsidiaries (Hartford and Firemans Fund)of both of my last 2 companies. The big difference between the US and UK is that pricing in the UK is much more complex (ignoring the 50 separate US jurisdictions which is a big complication). The DLG dataset and understanding of UK customer online insurance behaviour gives them a big head start, even if Lemonade bring outstanding IT and marketing. I recall when Swiftcover grew in the UK. The reason they are no longer material (not sure if Axa even use the brand today) is that they lost the pricing war - made huge UW losses because they lacked data and analysis (and were run by salesmen who made Shyster and Flywheel look like saints, and sold Axa a massive pup). But it will be interesting to see how things pan out. Absent a bid I can only see DLG as range bound.
sufc555: I’m not sure how relevant your point is re solvency capital ratio since dlg’s current rating is about double that required by ‘tedious’; regulations ie solvency 2 - last August it was 192% - possibly will now exceed 200% given the current low level of new rta claims. This excess capital is dlg’s choice in exceptional circumstances - hopefully those who hold and then sell pre ex divi will be burnt either by a takeover or significant buy backs An increase in IPt will have zero negative affect upon share price - the last significant increase in this tax 33% increase in 2015 actually resulted in an increase in the share price - and was in fact one of the best years for dlg However we shall see
fllegend: Re. differential between Admiral and DLG share price hit - Admiral has a much smaller home insurance portfolio than DLG. The FCA has identified that big profit margins and hiking prices on renewal is much worse in home than motor, so the negative impact on margins will likely be much bigger in home market than motor.
Direct Line Insurance share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Direct Lin..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210922 07:06:50